Nomura Holdings
RARE icon

Nomura Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History

Nomura Holdings’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29,800
Closed -$896K – 2115
2025
Q3 		$896K Buy
29,800
+21,400
+255% +$642K ﹤0.01% 1431
2025
Q2 		$305K Buy
+8,400
New +$303K ﹤0.01% 1235

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Nomura Holdings's RARE Position: Q1 2026 in Review

Nomura Holdings opened a new position in Ultragenyx Pharmaceutical (RARE) in Q1 2026: 30,000 shares worth $629K. The stake represents ﹤0.01% of the portfolio and ranks #1298 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in RARE as recently as Q2 2025.

Nomura Holdings first reported a position in RARE in Q4 2019 and has held it in 7 quarters since. The position peaked at $13.2M in Q1 2023. 296 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Nomura Holdings held 30,000 shares of Ultragenyx Pharmaceutical worth $629K as of Q1 2026.
  • Ultragenyx Pharmaceutical was a new Nomura Holdings position in Q1 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1298 holding.
  • Nomura Holdings first reported a position in Ultragenyx Pharmaceutical in Q4 2019 and has held it in 7 quarters since.
  • Nomura Holdings's Ultragenyx Pharmaceutical position peaked at $13.2M in Q1 2023.
  • 296 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.